Can Disinfecting the Air Itself Cut What’s Floating in a Clinical Space?

Updated Nov 1, 2026 — added the free upper-air UV quick card, go / no-go pack, and clean air verifier downloads to this guide.

A Canadian coalition is about to test upper-air UV in real hospitals. Here is what the lab numbers do — and do not — prove, and what your facility would have to measure before trusting them.

The direct answer

Upper-air ultraviolet is established technology. Hospitals have used it for more than 70 years, mostly against tuberculosis, and the CDC treats it as a legitimate way to add clean air to an occupied room.

What is new is the size of the claim now attached to one device — and the fact that it is about to be tested where it counts.

On October 28, 2026, the Coalition for Community & Healthcare Acquired Infection Reduction (CHAIR) announced facility-wide hospital pilots of SaniLume, a fan-assisted upper-air UV device made in Ottawa by Illumisoft.

CHAIR has signed letters of intent with Shared Health and Winnipeg’s Health Sciences Centre, and with British Columbia’s Provincial Health Services Authority.

Letters of intent are not installations. CHAIR’s own release says the studies are intended to start in November, subject to funding. That honesty is worth noting, because it frames everything below: this is a well-built question, not a finished answer.

The question the pilot is asking

Hospitals have engineered cleaner surfaces, cleaner sinks, and rooms disinfected between patients. None of that treats the air while care is underway.

Respiratory viruses — influenza, COVID-19, RSV — move through shared indoor air, often from people who do not yet know they are infected.

CHAIR’s program pairs facility-wide installations with 13 linked studies. The first two, with the University of Waterloo, compare ventilation rates with and without upper-air UV in a chamber, and model how air moves through patient rooms and waiting areas.

The program’s stated targets are specific: more than 90% reduction in airborne pathogens measured in real time in clinical spaces, more than 50% reduction in surface contamination, and more than 30% reduction in onward transmission of respiratory illness.

Read those numbers carefully. They are targets. The pilot exists to find out whether they are reachable.

Where the big laboratory numbers come from

The confidence behind the program comes from testing at the University of Leeds, reported by Dr. Louise Fletcher in August 2022.

In an aerobiology chamber — a patient-sized room ventilated at 6 air changes per hour, with test organisms released continuously while the device ran — SaniLume reduced airborne Staphylococcus aureus, Pseudomonas aeruginosa, and the virus surrogate Phi-6 by 97% to 98% at its lowest setting, and by 99.1% to 99.7% at maximum.

The Leeds report described it as the best-performing upper-room UV device tested in that chamber to date, at an estimated 216 to 1,994 equivalent air changes per hour. The best conventional device previously tested there managed roughly 8 to 12.

Those are strong chamber results, independently reported by a university lab. Secondary coverage describes the testing as company-funded — and it was still a chamber, not an occupied ward across a flu season. That gap is the entire reason the hospital pilot matters.

What the established evidence already supports

Upper-room UVGI is not experimental. CDC guidance describes it as a disinfection zone above the occupants: air circulates up, pathogens are inactivated, and the benefit is expressed as equivalent clean air added to the room.

The strongest field evidence is from tuberculosis. In a 2009 study in Lima, Peru, air from a TB ward was vented to test chambers on alternating days. Infection rates were 35% on control days and 9.5% on days the ward’s upper-room UV and mixing fans were on.

ASHRAE Standard 241, the current standard for control of infectious aerosols, counts ventilation, filtration, and air cleaning like UV together as equivalent clean airflow. It does not rank the technologies. It sets the clean-air target and lets a facility meet it with a combination.

That is the right frame for a facility director. The question is never UV or ventilation. It is how much verified clean air each option adds in your rooms, at what cost, and with what upkeep.

What your facility would have to prove

The room has to qualify. CDC guidance says upper-room UVGI needs spaces at least 8 feet tall, with 8.5 feet preferred, and some air movement. Low ceilings and still air are where these systems underperform.

The occupied zone has to be measured, not assumed. The accepted exposure limit for 254 nm UV is 6.0 mJ/cm² over eight hours. A credible installation is commissioned with a calibrated meter at eye level, and re-checked after any change.

Maintenance has to have a name attached. The guideline literature is blunt: UV systems fail quietly through dusty lamps, dead lamps left in place, and fans switched off. Lamps need scheduled cleaning and replacement, and a maintenance log a surveyor can open. (Our Environment of Care rounds piece covers how that documentation holds up.)

The baseline has to come first. In infection-control terms, an engineered air control sits inside your physical environment and infection prevention programs — §482.41 and §482.42 territory under the CMS Conditions of Participation. A pilot that cannot show before-and-after air measurements in the same occupied spaces, across a respiratory season, has shown a purchase, not a result.

The bottom line for operators

CHAIR estimates upper-air UV protection at about $5,000 per bed plus a few hundred dollars a year to run — CHAIR’s figures, not yet tested in this program’s own health-economics study, which is one of the 13 planned.

If the hospital pilots hit even part of their targets, disinfecting the air itself becomes a standard line in facility planning. If they do not, the chamber numbers join a long list of lab results that real buildings could not reproduce.

Either way, the discipline is the one you already use: baseline first, measure in the occupied room, maintain it like you mean it, and let the data — not the brochure — make the case.